MATINAS BIOPHARMA HOLDINGS, INC. Increase (Decrease) in Accounts Receivable and Other Operating Assets
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) reported Increase (Decrease) in Accounts Receivable and Other Operating Assets of $89.81 thousand for the 6-month period ending 2018-06-30, per its 10-Q filed 2019-08-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets · last filed 2019-08-13
- 2018-06-30: Increase (Decrease) in Accounts Receivable and Other Operating Assets 6 month $89.81K.
| Period end | Increase (Decrease) in Accounts Receivable and Other Operating Assets 6 month |
|---|---|
| 2018-06-30 | $89.81K 10-Q · filed 2019-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |